Tag: Chronic Lymphocytic Leukemia

Introduction Brukinsa (zanubrutinib) and Jaypirca (pirtobrutinib) are two targeted cancer therapies used to treat Chronic Lymphocytic Leukemia (CLL). Over the last decade, CLL has transitioned from chemotherapy to targeted therapies…